Yahoo
The FDA approves Sanofi's Qfitlia as the first therapy in the United States to treat hemophilia A or B with or without inhibitors.
Yahoo
CAMBRIDGE, Mass., April 01, 2025--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that management will present a company overview at the Needham 24th Annual Virtual Healthcare Conference on Tuesday, April 8, 2025 at 11:45 am ET.
Finnhub
CAMBRIDGE - Alnylam Pharmaceuticals, Inc. , the leading RNAi therapeutics company, today announced moderated poster presentations of new data from the landmark HELIOS-B Phase 3 clinical trial, which...
Yahoo
Alnylam Pharmaceuticals (NasdaqGS:ALNY) saw a 13% share price increase in the last quarter, propelled by the FDA approval of Qfitlia™ for hemophilia A or B, a significant milestone reflecting its leadership in RNAi therapeutics. Despite broader market declines due to renewed tariff concerns impacting sectors like auto, Alnylam's R&D advancements and robust earnings report, showing nearly 35% growth in revenue, likely contributed to the stock's positive performance. The company's strategic...
Yahoo
CAMBRIDGE, Mass., March 29, 2025--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced moderated poster presentations of new data from the landmark HELIOS-B Phase 3 clinical trial, which evaluated vutrisiran for the treatment of ATTR amyloidosis with cardiomyopathy (ATTR-CM) in a population representative of today’s patients. Data were presented at the American College of Cardiology’s Annual Scientific Session (ACC.25) held in Chicago, Illinois. Th
Finnhub
Alnylam Pharmaceuticals, Inc. announced moderated poster presentations of new data from the HELIOS-B Phase 3 clinical trial, which evaluated vutrisiran for the treatment of ATTR amyloidosis with...
Double maintains 8 strategies that include ALNY - Alnylam Pharmaceuticals, Inc.
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
SEG | -20.08% | $269.93M | -17.45% | 0.00% |
CBOE | -15.07% | $23.50B | +25.53% | 1.05% |
SON | -13.06% | $4.72B | -15.93% | 4.50% |
RMD | -12.60% | $32.75B | +19.87% | 0.97% |
HEES | -11.65% | $3.51B | +50.35% | 1.17% |
CMTL | -11.25% | $47.84M | -46.73% | 0.00% |
INSP | -9.25% | $4.75B | -24.09% | 0.00% |
DESP | -9.10% | $1.59B | +55.78% | 0.00% |
MNSO | -9.05% | $5.95B | -9.15% | 1.56% |
NXT | -8.99% | $6.26B | -16.38% | 0.00% |
SXC | -8.93% | $779.41M | -18.37% | 5.24% |
LFVN | -8.84% | $201.45M | +161.40% | 1.08% |
CHD | -8.82% | $26.66B | +5.00% | 1.03% |
DQ | -8.50% | $1.19B | -32.55% | 0.00% |
FBRT | -8.35% | $1.04B | -1.86% | 11.34% |
PTMN | -8.22% | - | - | 18.36% |
DBD | -7.92% | $1.68B | +35.21% | 0.00% |
CGNX | -7.84% | $5.18B | -25.04% | 1.15% |
GORV | -7.83% | $32.00M | -92.53% | 0.00% |
IRBT | -7.78% | $76.57M | -69.33% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
IONS | 49.97% | $4.56B | -34.42% | 0.00% |
ARGX | 41.40% | $35.46B | +46.46% | 0.00% |
RXO | 39.07% | $3.19B | -9.11% | 0.00% |
AMWL | 36.43% | $111.61M | -52.96% | 0.00% |
RARE | 29.19% | $3.27B | -24.87% | 0.00% |
ARWR | 28.35% | $1.74B | -52.08% | 0.00% |
BEAM | 27.33% | $1.85B | -37.74% | 0.00% |
NBIX | 27.13% | $10.80B | -21.28% | 0.00% |
MNKD | 26.66% | $1.52B | +13.32% | 0.00% |
RCKT | 26.58% | $671.77M | -75.23% | 0.00% |
CDNA | 26.50% | $1.02B | +83.17% | 0.00% |
LLY | 25.86% | $775.66B | +5.44% | 0.68% |
TVTX | 25.83% | $1.59B | +157.02% | 0.00% |
REGN | 25.65% | $68.39B | -34.21% | 0.00% |
LH | 25.57% | $19.78B | +11.37% | 1.24% |
BHVN | 25.53% | $2.42B | -54.71% | 0.00% |
MIRM | 25.40% | $2.21B | +81.89% | 0.00% |
AMGN | 25.28% | $164.22B | +11.40% | 2.96% |
EOLS | 25.08% | $777.03M | -10.01% | 0.00% |
BPMC | 24.90% | $5.75B | -2.41% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BBH | 46.70% | $358.88M | 0.35% |
FBT | 46.61% | $1.08B | 0.56% |
IBB | 43.91% | $5.61B | 0.45% |
XBI | 41.03% | $4.76B | 0.35% |
PBE | 40.76% | $224.98M | 0.58% |
GNOM | 39.54% | $47.13M | 0.5% |
PINK | 36.14% | $138.92M | 0.5% |
FHLC | 36.07% | $2.65B | 0.084% |
VHT | 35.71% | $16.17B | 0.09% |
IYH | 35.54% | $3.15B | 0.39% |
IHE | 34.10% | $588.93M | 0.39% |
FXH | 33.38% | $954.59M | 0.62% |
PTH | 32.50% | $107.91M | 0.6% |
XPH | 32.50% | $158.14M | 0.35% |
IXJ | 32.24% | $3.89B | 0.41% |
XLV | 32.07% | $37.76B | 0.09% |
PPH | 28.14% | $651.33M | 0.36% |
ARKG | 27.77% | $936.86M | 0.75% |
QQQJ | 25.45% | $592.09M | 0.15% |
RSPH | 24.79% | $784.50M | 0.4% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
TPMN | -18.35% | $33.32M | 0.65% |
VIXY | -14.60% | $195.31M | 0.85% |
BTAL | -13.81% | $416.76M | 1.43% |
DBA | -11.75% | $829.48M | 0.93% |
KMLM | -9.77% | $218.49M | 0.9% |
TAIL | -9.48% | $87.65M | 0.59% |
VRIG | -7.88% | $1.44B | 0.3% |
USDU | -7.31% | $206.96M | 0.5% |
AFIF | -6.64% | $135.91M | 1.11% |
UUP | -6.17% | $325.79M | 0.77% |
YEAR | -6.08% | $1.28B | 0.25% |
CPRJ | -5.98% | $48.38M | 0.69% |
CLOI | -5.41% | $1.01B | 0.4% |
EFAA | -5.41% | $100.03M | 0% |
JMST | -5.31% | $3.54B | 0.18% |
USFR | -4.90% | $18.53B | 0.15% |
HYD | -4.82% | $3.45B | 0.32% |
USCI | -4.13% | $240.82M | 1.07% |
BILZ | -4.05% | $734.41M | 0.14% |
CNYA | -3.90% | $218.06M | 0.6% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTCW | -0.01% | $149.65M | 0.3% |
BRRR | 0.01% | $491.80M | 0.25% |
PDBC | -0.03% | $4.89B | 0.59% |
BITB | -0.03% | $3.26B | 0.2% |
CXSE | 0.03% | $428.68M | 0.32% |
ULST | -0.04% | $585.14M | 0.2% |
GBTC | -0.05% | $16.42B | 1.5% |
IBHE | 0.05% | $590.52M | 0.35% |
IBIT | 0.06% | $48.97B | 0.25% |
HODL | 0.10% | $1.18B | 0.25% |
ARKB | -0.11% | $3.95B | 0.21% |
FBTC | 0.11% | $16.65B | 0.25% |
GCC | -0.13% | $149.77M | 0.55% |
BNO | -0.18% | $99.25M | 1% |
EZBC | -0.19% | $428.53M | 0.29% |
BTCO | 0.20% | $449.44M | 0.39% |
BITO | 0.21% | $2.22B | 0.95% |
BUXX | -0.27% | $234.79M | 0.25% |
AGZD | -0.32% | $134.05M | 0.23% |
OILK | -0.33% | $67.85M | 0.69% |
Current Value
$263.001 Year Return
Current Value
$263.001 Year Return
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
ML | -<0.01% | $984.51M | +23.19% | 0.00% |
BLDR | -0.01% | $14.90B | -35.34% | 0.00% |
GAN | -0.01% | $81.06M | +31.11% | 0.00% |
CCJ | 0.01% | $18.49B | -14.82% | 0.28% |
VNDA | -0.02% | $263.01M | -10.69% | 0.00% |
SII | -0.03% | $1.16B | +13.71% | 2.51% |
VTOL | 0.03% | $944.86M | +21.06% | 0.00% |
DE | -0.03% | $127.81B | +15.98% | 1.36% |
ACMR | 0.03% | $1.48B | -25.06% | 0.00% |
ACIC | 0.04% | $549.55M | +9.94% | 0.00% |
FNKO | 0.05% | $368.05M | +12.52% | 0.00% |
TRV | 0.05% | $59.97B | +15.47% | 1.60% |
CCSI | 0.06% | $459.05M | +53.56% | 0.00% |
SOC | -0.07% | $2.34B | +139.36% | 0.00% |
GREE | -0.07% | $8.64M | -76.54% | 0.00% |
WMS | -0.08% | $8.53B | -34.35% | 0.63% |
AMRK | 0.08% | $581.70M | -20.21% | 3.40% |
HSIC | -0.08% | $8.60B | -5.71% | 0.00% |
HD | -0.09% | $368.68B | +3.05% | 2.53% |
MYRG | -0.10% | $1.93B | -31.60% | 0.00% |